Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01018940 · ClinicalTrials.gov registry record
Influence of the Proton Pump Inhibitor Omeprazole on the Anti-Platelet of P2Y12 Antagonists in Subjects With Coronary and Peripheral Artery Disease
A clinical trial, sponsored by University of Oklahoma.
- Completed
- Registry status
- 30
- Enrollment target
NCT01018940 is a clinical trial that has completed, run by University of Oklahoma. The registered enrollment target is 30 participants.
The verdict
NCT01018940 has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
To determine if prasugrel is superior to clopidogrel in providing adequate antiplatelet effect in a high risk population that requires concomitant use of a Proton Pump Inhibitor (PPI).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2010-01 |
| Est. Completion | 2011-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01018940
The ClinicalTrials.gov registry entry for NCT01018940 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01018940 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01018940 about?
NCT01018940 is a clinical study titled "Influence of the Proton Pump Inhibitor Omeprazole on the Anti-Platelet of P2Y12 Antagonists in Subjects With Coronary and Peripheral Artery Disease". To determine if prasugrel is superior to clopidogrel in providing adequate antiplatelet effect in a high risk population that requires concomitant use of a Proton Pump Inhibitor (PPI).
What is the current status of trial NCT01018940?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2010-01. Estimated completion is 2011-06.
Who is sponsoring clinical trial NCT01018940?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.